Romain Devillers
Laval University
3 Papers
Romain Devillers is an academic researcher from Laval University. The author has contributed to research in topics: Calcific aortic valve stenosis & Enhancer. The author has an hindex of 1, co-authored 3 publications.
Chat about Author
Papers
Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis.
Raphaëlle Bourgeois,Romain Devillers,Nicolas Perrot,Audrey-Anne Després,Marie-Chloé Boulanger,Patricia L. Mitchell,Jakie Guertin,Patrick Couture,Michael B. Boffa,Corey A. Scipione,Philippe Pibarot,Marlys L. Koschinsky,Patrick Mathieu,Benoit J. Arsenault +13 more
TL;DR: In this article, the autotaxin (ATX) was found to preferentially transport by low-density lipoprotein fractions in isolated fractions of 10 healthy participants.
Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesis
Arnaud Chignon,Mickael Rosa,Marie-Chloé Boulanger,Deborah Argaud,Romain Devillers,Valentin Bon-Baret,Ghada Mkannez,Zhonglin Li,Anne Rufiange,Nathalie Gaudreault,David Gosselin,Sébastien Thériault,Yohan Bossé,Patrick Mathieu +13 more
TL;DR: In this article, the authors used 3D genetic mapping and CRISPR activation to identify rs6702619 as being located in a distant-acting enhancer, which controls the expression of PALMD.
ZNF768 links oncogenic RAS to cellular senescence.
Romain Villot,Audrey Poirier,Inan Bakan,Karine Boulay,Erlinda Fernández,Romain Devillers,Luciano Gama-Braga,Laura Tribouillard,Andréanne Gagné,Éma Duchesne,Danielle Caron,Danielle Caron,Jean-Sébastien Bérubé,Jean-Christophe Bérubé,Yan Coulombe,Michèle Orain,Yves Gélinas,Stéphane Gobeil,Yohan Bossé,Jean-Yves Masson,Sabine Elowe,Steve Bilodeau,Venkata S. K. Manem,Philippe Joubert,Frédérick A. Mallette,Mathieu Laplante +25 more
TL;DR: In this article, the authors identify ZNF768 as a phosphoprotein destabilized upon RAS activation, which impairs proliferation and induces senescence by modulating the expression of key cell cycle effectors and established p53 targets.